While leprosy might seem like an ancient disease to many, it is very much the disease of the present in the 145 countries where it still affects people: in 2016, there were more than 200.000 new cases registered globally.

Within the framework of the PEOPLE project, a large, multi-partner clinical trial, four methods of preventive treatment will be tested to stop the disease in the Comoros and Madagascar, which are the two most affected countries. Nearly 150.000 contacts of leprosy patients to participate are planned to participate in this large-scale study.

The PEOPLE study is led by ITM, which has a longstanding expertise in disease caused by mycobacteria, such as TB, Buruli ulcer and leprosy. The consortium includes:

 

 
 
 

This project is part of the EDCTP2 programme supported by the European Union:

Latest events

Annual Meeting with Consortium of PEOPLE in Manila

10/09/2019

Annual Meeting with Consortium of PEOPLE in Manila

20th International Leprosy Congress

11/09/2019 - 13/09/2019

The International Leprosy Association (ILA) once again presents its compliments to the Philippines authorities for accepting to host the 20th International Leprosy Congress (20th ILC).

Latest news

PEOPLE during Covid-19

September 17, 2020

In the first year of the PEOPLE study (2019), a total of 101,994 persons were identified of whom 95,679 agreed to participate in the study and were examined for signs of leprosy by the local screening teams. Amongst these participants, 428 new leprosy patients were identified, of whom 325 in Anjouan (The Comoros), 38 in […]

Newsletter #1

July 22, 2019

The PEOPLE project has completed its first year. Read all about it...